Skip to content
Open access

6‐Aminoflavone Inhibits Planktonic Growth, Disrupts Biofilm Architecture, and Regulates Quorum Sensing in Klebsiella pneumoniae

Jan 2026 · Biochemistry Research International · Vol 2026 · 0 citations · 71 references
Medicine

TL;DR

It is demonstrated that 6‐Aminoflavone exerts antimicrobial activity by inducing oxidative stress–mediated apoptosis‐like bacterial death, disrupting biofilm structural components, and suppressing QS‐regulated virulence in K. pneumoniae.

Abstract

Antibiotic resistance has emerged as a major global health challenge, particularly in biofilm‐forming pathogens that exhibit enhanced tolerance to antimicrobial therapies. K. pneumoniae, a multidrug‐resistant pathogen, is a leading cause of hospital‐acquired infections, including pneumonia, septicemia, and device‐associated infections. Its robust biofilm‐forming capacity facilitates immune evasion, restricts antibiotic penetration, and contributes to recurrent infections. Therefore, the identification of agents capable of targeting both planktonic bacterial growth and biofilm architecture is of considerable therapeutic importance. In the present study, the antibacterial, antibiofilm, and antivirulence potential of 6‐Aminoflavone was investigated against K. pneumoniae. Antibacterial activity was evaluated using growth inhibition assays, time–kill kinetics, and clonogenic survival analysis. Mechanistic investigations revealed significant intracellular ROS accumulation, increased oxidative stress susceptibility, and induction of apoptosis‐like cell death, suggesting ROS‐mediated antibacterial activity. In addition to suppressing bacterial proliferation, 6‐Aminoflavone exhibited promising antibiofilm efficacy, inhibiting biofilm formation by 86.23% and eradicating 84.77% of established biofilms. These effects were associated with a substantial reduction in cell surface hydrophobicity (∼45.39%), and EPS levels were reduced to ∼2.33% as compared to untreated controls, indicating severe destabilization of the biofilm matrix. Furthermore, eDNA, a key structural component of the biofilm scaffold, exhibited a maximum ∼2.13‐fold reduction following treatment. Confocal microscopy confirmed marked disruption and collapse of biofilm architecture. Additionally, quorum sensing (QS)–regulated virulence factors, including urease (∼51.92%), protease (∼55.18%), and lipase (∼44.90%), were significantly attenuated. These findings demonstrate that 6‐Aminoflavone exerts antimicrobial activity by inducing oxidative stress–mediated apoptosis‐like bacterial death, disrupting biofilm structural components, and suppressing QS‐regulated virulence in K. pneumoniae.

Read PDF

Similar papers

Open access Oct 2026

4-Hydroxycoumarin inhibits biofilm formation and enhances antibiotic efficacy against Escherichia coli O157:H7

Conventional bactericidal antibiotics often fail to eradicate Escherichia coli O157:H7 ( E. coli O157) infections due to biofilm-mediated antimicrobial tolerance, and monotherapy can inadvertently drive resistance selection. This study aimed to identify compounds capable of modulating LuxS/AI-2-related phenotyp...

Hong-Xing Zhang, Jing Xu, Ya-Xin Zhou et al. · 0 citations
Open access Sep 2026

Phage–Antibiotic–Peptide Synergy Overcomes Biofilm-Mediated Multidrug Resistance in Serratia marcescens

It is demonstrated that simultaneous targeting of multiple bacterial pathways can enhance antimicrobial activity against MDR S. marcescens in vitro and support further evaluation of BAP as a potential strategy for biofilm-associated infections.

Aryaan P. Duggal, Adit B. Alreja, Isha Vashee et al. · 0 citations
Open access Sep 2026

3-Hydroxyflavone Inhibits Biofilm Formation and Enhances Antibiotic Activity Against Enterococcus faecalis and Enterococcus faecium

Background/Objectives: The increasing antibiotic resistance of pathogenic bacteria has created an urgent need for new therapies that target virulence factors. Biofilm formation is a major determinant of bacterial pathogenicity and antimicrobial resistance. Methods: Biofilm formation assays (using crystal violet stainin...

Jimin Yoon, Ye-ji Kim, Ki-Young Kim · 0 citations
#protein folding Open access Oct 2026

Ertapenem Exposure Is Associated with Downregulation of Purine Biosynthesis Proteins and Inhibition of Biofilm Formation in Staphylococcus aureus

This study demonstrates that ertapenem exhibits potent antibacterial activity against S. aureus and is a potential inhibitor of biofilm formation, and implicates a novel aspect of ertapenem’s activity connected to the disruption of purine biosynthesis in S. aureus through targeted downregulation of FGAM synthase.

Anamika Singh, Surabhi Pandit, Pradeep Pant et al. · 0 citations
Review Open access Sep 2026

The interface of biofilm and immune system for Gram-negative ESKAPE pathogens

ABSTRACT The ESKAPE group of pathogens comprises Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp., which are capable of developing profound biofilms while infecting host tissues and medical devices. In addition to acting as a barr...

Shatarupa Biswas, Sayan Bhattacharyya, Sonali Biswas et al. · 0 citations
Review Aug 2026

Staphylococcus aureus biofilms: molecular mechanisms, resistance determinants, and emerging therapeutic strategies

This review aims to provide a comprehensive and up-to-date overview of the molecular biology of S. aureus biofilms, biofilm-associated antimicrobial resistance, interactions with the host, polymicrobial interactions, and emerging therapeutic strategies, and to highlight the ongoing challenges and future directions in t...

Mohd. Saleem, A. S. Syed Khaja, Irfan Ahmad et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.